The "Elevate" by MAPS Podcast

As Medical Affairs professionals, we are starting to capitalize on the promise of Real-World Evidence. However, the more we accomplish, the more untapped potential we see. This podcast looks beyond the obvious uses of RWE to explore emerging opportunities for Medical Affairs professionals and teams to leverage this powerful source of data to benefit patients.

This podcast series will focus on how digital is transforming scientific communications. Episode 2 will focus on different forms of enhanced publication content (EPC) and new approaches that might change manuscript development.

Medical Affairs was conceptualized in a primarily executional role, closely linked with an organization’s sales function. Now, as Medical Affairs has become the organization’s voice of scientific expertise, and in a climate of increased patient-centricity and increased scrutiny, Medical Affairs has taken on an increasingly strategic role. Here MAPS speaks with Ariel Katz, co-founder and CEO of H1 Insights about the factors driving the evolution of Medical Affairs and look at the shape of the function in 2030 and beyond.

This podcast series will focus on how digital is transforming scientific communications.  Episode 1 will focus on the journal publishing industry, discussing how medical journal publishing is changing and what changes we might see in the future.

In this podcast, Kirk Shepard, Chief Medical Officer & SVP, Head of Global Medical Affairs OBG at Eisai, speaks with Ghazaleh EA, pharmacist and new industry professional. The conversation explores Ghazaleh's path into Medical Affairs and covers topics including the transition from training to industry, the plusses and minuses of clinical practice versus direct industry involvement, internships, challenges of finding a first position, and how to discover your specialty within the function. 

As we all know as per the FDA – October is ‘Cybersecurity Awareness Month’ and today we are going to talk and discuss about this critically important topic. Our objectives for this podcast are as follows:

1. What is medical device cybersecurity – why should you care?

2. Why does the FDA and other agencies care about medical device cybersecurity?

3. What are the regulatory expectations?

Objectives:

At the end of this series of podcasts, the participant will be able to:

• Discuss the functions and activities of key external stakeholders
• Identify potential areas for compliant collaboration by MSLs with Academic Drug Developers

This podcast sponsored by VISFO explores the past, present and future of the Medical Science Liaison role, from its origin as a primarily sales-focused transactional position, to one of increasing strategic importance to the organization in which MSLs engage in a two-way dialogue with HCPs, KOLs and others within the ecosystem of external stakeholders to drive better patient care. 

Objectives:

At the end of this series of podcasts, the participant will be able to:

• Discuss the functions and activities of key external stakeholders
• Identify potential areas for compliant collaboration by MSLs with Patient Advocacy Groups

Historically, insight gathering in life science has been a fragmented process, when it should be viewed as a single endeavor. In this discussion sponsored by Within3, learn how to eliminate the insight gaps that occur due to disparate data sets, changing stakeholders, siloed information systems, and evolving scientific narratives throughout the product development lifecycle – and how Medical Affairs teams can achieve clarity, improve business function, and reduce risk with a holistic, technology-enabled approach.